Advertisement | | New publication: Best practices for low input ChIP-seq ChIP-seq has become the gold standard to investigate genome-wide epigenetic profiles. However, ChIP from limited cell inputs has been challenging. Diagenode and Advanced Analytical Technologies, Inc. (AATI) provide first complete and robust workflow solution for ChIP-seq from very small numbers of cells using critical quality checkpoints to assure success.
Read the new publication. | | | | | |
TABLE OF CONTENTS
| | | | Volume 36, Issue 24 (June 2017) | | In this issue Review Original Articles Corrigendum
Also new AOP | | | | | Advertisement | | | | | Review | Top | | Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches OPENC C Wong, Y Qian and J Yu Oncogene 2017 36: 3359-3374; advance online publication, January 16, 2017; 10.1038/onc.2016.485 Abstract | Full Text | | Original Articles | Top | | Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications OPEND Amar, S Izraeli and R Shamir Oncogene 2017 36: 3375-3383; advance online publication, January 16, 2017; 10.1038/onc.2016.489 Abstract | Full Text | | | | An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasisL Zhao, G Ji, X Le, Z Luo, C Wang, M Feng, L Xu, Y Zhang, W B Lau, B Lau, Y Yang, L Lei, H Yang, Y Xuan, Y Chen, X Deng, T Yi, S Yao, X Zhao, Y Wei and S Zhou Oncogene 2017 36: 3384-3396; advance online publication, January 23, 2017; 10.1038/onc.2016.487 Abstract | Full Text | | | | Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cellsJ F van Lidth de Jeude, B J Meijer, M C B Wielenga, C N Spaan, B Baan, S L Rosekrans, S Meisner, Y H Shen, A S Lee, J C Paton, A W Paton, V Muncan, G R van den Brink and J Heijmans Oncogene 2017 36: 3397-3405; advance online publication, November 7, 2016; 10.1038/onc.2016.326 Abstract | Full Text | | | | The Nogo-B receptor promotes Ras plasma membrane localization and activationB Zhao, W Hu, S Kumar, P Gonyo, U Rana, Z Liu, B Wang, W Q Duong, Z Yang, C L Williams and Q R Miao Oncogene 2017 36: 3406-3416; advance online publication, January 9, 2017; 10.1038/onc.2016.484 Abstract | Full Text | | | | Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality OPENB W C Tse, M Volpert, E Ratther, N Stylianou, M Nouri, K McGowan, M L Lehman, S J McPherson, M Roshan-Moniri, M S Butler, J Caradec, C Y Gregory-Evans, J McGovern, R Das, M Takhar, N Erho, M Alshalafa, E Davicioni, E M Schaeffer, R B Jenkins, A E Ross, R J Karnes, R B Den, L Fazli, P A Gregory, M E Gleave, E D Williams, P S Rennie, R Buttyan, J H Gunter, L A Selth, P J Russell, C C Nelson and B G Hollier Oncogene 2017 36: 3417-3427; advance online publication, January 16, 2017; 10.1038/onc.2016.482 Abstract | Full Text | | | | FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells OPENN Yang, C Wang, Z Wang, S Zona, S-X Lin, X Wang, M Yan, F-M Zheng, S-S Li, B Xu, L Bella, J-S Yong, E W-F Lam and Q Liu Oncogene 2017 36: 3428-3440; advance online publication, January 23, 2017; 10.1038/onc.2016.490 Abstract | Full Text | | | | HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironmentA Guo, P Lu, J Lee, C Zhen, G Chiosis and Y L Wang Oncogene 2017 36: 3441-3449; advance online publication, January 23, 2017; 10.1038/onc.2016.494 Abstract | Full Text | | | | Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL OPENE Hasanov, G Chen, P Chowdhury, J Weldon, Z Ding, E Jonasch, S Sen, C L Walker and R Dere Oncogene 2017 36: 3450-3463; advance online publication, January 23, 2017; 10.1038/onc.2016.495 Abstract | Full Text | | | | The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinomaC Hermanns, V Hampl, K Holzer, A Aigner, J Penkava, N Frank, D E Martin, K C Maier, N Waldburger, S Roessler, M Goppelt-Struebe, I Akrap, A Thavamani, S Singer, A Nordheim, T Gudermann and S Muehlich Oncogene 2017 36: 3464-3476; advance online publication, January 23, 2017; 10.1038/onc.2016.496 Abstract | Full Text | | | | The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesisH Yi, L Geng, A Black, G Talmon, L Berim and J Wang Oncogene 2017 36: 3477-3489; advance online publication, January 23, 2017; 10.1038/onc.2016.499 Abstract | Full Text | | | | The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancerY He, J J Northey, A Pelletier, Z Kos, L Meunier, B Haibe-Kains, A-M Mes-Masson, J-F Côté, P M Siegel and N Lamarche-Vane Oncogene 2017 36: 3490-3503; advance online publication, January 30, 2017; 10.1038/onc.2016.492 Abstract | Full Text | | Corrigendum | Top | | CFTR is a tumor suppressor gene in murine and human intestinal cancerB L N Than, J F Linnekamp, T K Starr, D A Largaespada, A Rod, Y Zhang, V Bruner, J Abrahante, A Schumann, T Luczak, J Walter, A Niemczyk, M G O'Sullivan, J P Medema, R J A Fijneman, G A Meijer, E Van den Broek, C A Hodges, P M Scott, L Vermeulen and R T Cormier Oncogene 2017 36: 3504; advance online publication, February 13, 2017; 10.1038/onc.2017.3 Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment